Insomnia Pharmacological Treatment Market Report

Global Insomnia Pharmacological Treatment Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 25, 2022
  • PAGES：195
  • REPORT CODE：GMM776045
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Insomnia Pharmacological Treatment market report explains the definition, types, applications, major countries, and major players of the Insomnia Pharmacological Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Meda Consumer Healthcare Inc (US)

    • Takeda Pharmaceutical Company Ltd (Japan)

    • Pfizer Inc (US)

    • Merck & Co Inc (US)

    • Pernix Therapeutics (US)

    • Purdue Pharma LP (US)

    • Sanofi (France)

    • Eisai, Co Ltd (Japan)

    By Type:

    • Prescription Sleep Aids

    • Over-the-Counter Sleep Aids

    By End-User:

    • Homecare

    • Clinic

    • Hospital

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Insomnia Pharmacological Treatment Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Insomnia Pharmacological Treatment Outlook to 2028- Original Forecasts

    • 2.2 Insomnia Pharmacological Treatment Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Insomnia Pharmacological Treatment Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Insomnia Pharmacological Treatment Market- Recent Developments

    • 6.1 Insomnia Pharmacological Treatment Market News and Developments

    • 6.2 Insomnia Pharmacological Treatment Market Deals Landscape

    7 Insomnia Pharmacological Treatment Raw Materials and Cost Structure Analysis

    • 7.1 Insomnia Pharmacological Treatment Key Raw Materials

    • 7.2 Insomnia Pharmacological Treatment Price Trend of Key Raw Materials

    • 7.3 Insomnia Pharmacological Treatment Key Suppliers of Raw Materials

    • 7.4 Insomnia Pharmacological Treatment Market Concentration Rate of Raw Materials

    • 7.5 Insomnia Pharmacological Treatment Cost Structure Analysis

      • 7.5.1 Insomnia Pharmacological Treatment Raw Materials Analysis

      • 7.5.2 Insomnia Pharmacological Treatment Labor Cost Analysis

      • 7.5.3 Insomnia Pharmacological Treatment Manufacturing Expenses Analysis

    8 Global Insomnia Pharmacological Treatment Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Insomnia Pharmacological Treatment Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Insomnia Pharmacological Treatment Export by Region (Top 10 Countries) (2017-2028)

    9 Global Insomnia Pharmacological Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Insomnia Pharmacological Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Prescription Sleep Aids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Over-the-Counter Sleep Aids Consumption and Growth Rate (2017-2022)

    • 9.2 Global Insomnia Pharmacological Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Homecare Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Hospital Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Insomnia Pharmacological Treatment Market Analysis and Outlook till 2022

    • 10.1 Global Insomnia Pharmacological Treatment Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.2.2 Canada Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.2.3 Mexico Insomnia Pharmacological Treatment Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.2 UK Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.3 Spain Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.4 Belgium Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.5 France Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.6 Italy Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.7 Denmark Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.8 Finland Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.9 Norway Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.10 Sweden Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.11 Poland Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.12 Russia Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.3.13 Turkey Insomnia Pharmacological Treatment Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.2 Japan Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.3 India Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.4 South Korea Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.5 Pakistan Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.6 Bangladesh Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.7 Indonesia Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.8 Thailand Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.9 Singapore Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.10 Malaysia Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.11 Philippines Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.4.12 Vietnam Insomnia Pharmacological Treatment Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.5.2 Colombia Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.5.3 Chile Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.5.4 Argentina Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.5.5 Venezuela Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.5.6 Peru Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.5.7 Puerto Rico Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.5.8 Ecuador Insomnia Pharmacological Treatment Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.6.2 Kuwait Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.6.3 Oman Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.6.4 Qatar Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Insomnia Pharmacological Treatment Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.7.2 South Africa Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.7.3 Egypt Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.7.4 Algeria Insomnia Pharmacological Treatment Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Insomnia Pharmacological Treatment Consumption (2017-2022)

      • 10.8.2 New Zealand Insomnia Pharmacological Treatment Consumption (2017-2022)

    11 Global Insomnia Pharmacological Treatment Competitive Analysis

    • 11.1 Meda Consumer Healthcare Inc (US)

      • 11.1.1 Meda Consumer Healthcare Inc (US) Company Details

      • 11.1.2 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Main Business and Markets Served

      • 11.1.4 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Takeda Pharmaceutical Company Ltd (Japan)

      • 11.2.1 Takeda Pharmaceutical Company Ltd (Japan) Company Details

      • 11.2.2 Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Main Business and Markets Served

      • 11.2.4 Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Pfizer Inc (US)

      • 11.3.1 Pfizer Inc (US) Company Details

      • 11.3.2 Pfizer Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Pfizer Inc (US) Insomnia Pharmacological Treatment Main Business and Markets Served

      • 11.3.4 Pfizer Inc (US) Insomnia Pharmacological Treatment Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck & Co Inc (US)

      • 11.4.1 Merck & Co Inc (US) Company Details

      • 11.4.2 Merck & Co Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck & Co Inc (US) Insomnia Pharmacological Treatment Main Business and Markets Served

      • 11.4.4 Merck & Co Inc (US) Insomnia Pharmacological Treatment Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Pernix Therapeutics (US)

      • 11.5.1 Pernix Therapeutics (US) Company Details

      • 11.5.2 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Main Business and Markets Served

      • 11.5.4 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Purdue Pharma LP (US)

      • 11.6.1 Purdue Pharma LP (US) Company Details

      • 11.6.2 Purdue Pharma LP (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Purdue Pharma LP (US) Insomnia Pharmacological Treatment Main Business and Markets Served

      • 11.6.4 Purdue Pharma LP (US) Insomnia Pharmacological Treatment Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sanofi (France)

      • 11.7.1 Sanofi (France) Company Details

      • 11.7.2 Sanofi (France) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sanofi (France) Insomnia Pharmacological Treatment Main Business and Markets Served

      • 11.7.4 Sanofi (France) Insomnia Pharmacological Treatment Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Eisai, Co Ltd (Japan)

      • 11.8.1 Eisai, Co Ltd (Japan) Company Details

      • 11.8.2 Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Main Business and Markets Served

      • 11.8.4 Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Insomnia Pharmacological Treatment Market Outlook by Types and Applications to 2028

    • 12.1 Global Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Prescription Sleep Aids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Over-the-Counter Sleep Aids Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Homecare Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Insomnia Pharmacological Treatment Market Analysis and Outlook to 2028

    • 13.1 Global Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.2.2 Canada Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.2 UK Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.3 Spain Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.5 France Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.6 Italy Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.8 Finland Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.9 Norway Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.11 Poland Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.12 Russia Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.2 Japan Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.3 India Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.5.3 Chile Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.5.6 Peru Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.6.3 Oman Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Insomnia Pharmacological Treatment

    • Figure of Insomnia Pharmacological Treatment Picture

    • Table Global Insomnia Pharmacological Treatment Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Insomnia Pharmacological Treatment Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Prescription Sleep Aids Consumption and Growth Rate (2017-2022)

    • Figure Global Over-the-Counter Sleep Aids Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Insomnia Pharmacological Treatment Consumption by Country (2017-2022)

    • Table North America Insomnia Pharmacological Treatment Consumption by Country (2017-2022)

    • Figure United States Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Canada Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Mexico Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Insomnia Pharmacological Treatment Consumption by Country (2017-2022)

    • Figure Germany Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure UK Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Spain Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Belgium Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure France Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Italy Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Denmark Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Finland Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Norway Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Sweden Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Poland Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Russia Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Turkey Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Table APAC Insomnia Pharmacological Treatment Consumption by Country (2017-2022)

    • Figure China Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Thailand Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Singapore Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Philippines Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Table South America Insomnia Pharmacological Treatment Consumption by Country (2017-2022)

    • Figure Brazil Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Colombia Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Chile Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Argentina Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Peru Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Table GCC Insomnia Pharmacological Treatment Consumption by Country (2017-2022)

    • Figure Bahrain Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Oman Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Qatar Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Table Africa Insomnia Pharmacological Treatment Consumption by Country (2017-2022)

    • Figure Nigeria Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Africa Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Egypt Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure Algeria Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Table Oceania Insomnia Pharmacological Treatment Consumption by Country (2017-2022)

    • Figure Australia Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)

    • Table Meda Consumer Healthcare Inc (US) Company Details

    • Table Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Main Business and Markets Served

    • Table Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Product Portfolio

    • Table Takeda Pharmaceutical Company Ltd (Japan) Company Details

    • Table Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Main Business and Markets Served

    • Table Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Product Portfolio

    • Table Pfizer Inc (US) Company Details

    • Table Pfizer Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc (US) Insomnia Pharmacological Treatment Main Business and Markets Served

    • Table Pfizer Inc (US) Insomnia Pharmacological Treatment Product Portfolio

    • Table Merck & Co Inc (US) Company Details

    • Table Merck & Co Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc (US) Insomnia Pharmacological Treatment Main Business and Markets Served

    • Table Merck & Co Inc (US) Insomnia Pharmacological Treatment Product Portfolio

    • Table Pernix Therapeutics (US) Company Details

    • Table Pernix Therapeutics (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pernix Therapeutics (US) Insomnia Pharmacological Treatment Main Business and Markets Served

    • Table Pernix Therapeutics (US) Insomnia Pharmacological Treatment Product Portfolio

    • Table Purdue Pharma LP (US) Company Details

    • Table Purdue Pharma LP (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Pharma LP (US) Insomnia Pharmacological Treatment Main Business and Markets Served

    • Table Purdue Pharma LP (US) Insomnia Pharmacological Treatment Product Portfolio

    • Table Sanofi (France) Company Details

    • Table Sanofi (France) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi (France) Insomnia Pharmacological Treatment Main Business and Markets Served

    • Table Sanofi (France) Insomnia Pharmacological Treatment Product Portfolio

    • Table Eisai, Co Ltd (Japan) Company Details

    • Table Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Main Business and Markets Served

    • Table Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Product Portfolio

    • Figure Global Prescription Sleep Aids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Over-the-Counter Sleep Aids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insomnia Pharmacological Treatment Consumption Forecast by Country (2022-2028)

    • Table North America Insomnia Pharmacological Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Insomnia Pharmacological Treatment Consumption Forecast by Country (2022-2028)

    • Figure Germany Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Insomnia Pharmacological Treatment Consumption Forecast by Country (2022-2028)

    • Figure China Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Insomnia Pharmacological Treatment Consumption Forecast by Country (2022-2028)

    • Figure Brazil Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Insomnia Pharmacological Treatment Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Insomnia Pharmacological Treatment Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Insomnia Pharmacological Treatment Consumption Forecast by Country (2022-2028)

    • Figure Australia Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US